S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.33
+1.65
+9.89%
SGHT · Sight Sciences, Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
$8.70
+0.07
(+0.81%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$8.70
$8.56
$8.79
52-WEEK RANGE
$8.70
$3.38
$9.71
What's happening
- SGHT is up 0.81% today, trading at $8.70. — Live quote
- Volume today (12,734) is well below its 3-month average of 254,919. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.08 actual vs. $-0.16 estimated (+49.1%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 4
Buy 6
Hold 4
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (14 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
SGHT
+8.70%
vs S&P 500
-4.08%
1-YEAR RETURN
SGHT
+84.98%
vs S&P 500
+70.42%
6-MONTH RETURN
SGHT
+125.07%
3-MONTH RETURN
SGHT
+75.56%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.08
Est. $-0.16
BEAT +49.1%
2026-04-26 (Q1 2026)
$-0.24
Est. $-0.17
MISS -42.3%
2026-01-26 (Q4 2025)
$-0.08
Est. $-0.14
BEAT +43.7%
2025-10-26 (Q3 2025)
$-0.16
Est. $-0.26
BEAT +37.8%
Valuation Measures & Ratios
Enterprise Value4$440.3M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)5.75
Price / Book75.58
EV4 / Revenue5.28
EV4 / EBITDA—
Profit Margin-35.69%
Operating Margin-33.43%
Return on Equity (ROE8)-50.64%
Return on Assets (ROA9)-26.68%
Avg Volume (3M)254,919
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $301.8M | $204.4M | $175.1M | $213.9M | $121.6M |
| P/E | -8.04 | -4.33 | -3.86 | -4.32 | -2.26 |
| Price/Sales | 3.66 | 2.67 | 2.27 | 2.72 | 1.55 |
| Price/Book | 5.71 | 3.79 | 2.72 | 3.06 | 1.57 |
| EV/Revenue | 3.18 | 2.09 | 1.59 | 1.94 | 0.67 |
| EV/EBITDA | -7.41 | -3.53 | -2.78 | — | — |
| ROE | -70.96% | -87.65% | -70.51% | -70.69% | -69.32% |
| ROA | -35.79% | -43.07% | -38.99% | -40.58% | -41.50% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short1,416,320
Change from Prior Settlement+13.05%
% of Float—
Days to Cover (Short Ratio)4.13
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 19.6% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +85.0%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -35.7%. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-05; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on SGHT
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23.4M | $19.7M | $19.9M | $19.6M | $17.5M | $20.2M | $21.4M | $19.3M |
| Gross profit | $21.4M | $17.0M | $17.2M | $16.6M | $15.1M | $16.9M | $18.3M | $16.5M |
| Operating income | -$3.9M | -$12.4M | -$7.9M | -$11.7M | -$13.9M | -$11.2M | -$12.7M | -$14.7M |
| Net income | -$4.4M | -$13.0M | -$8.2M | -$11.9M | -$14.2M | -$11.1M | -$12.3M | -$16.3M |
| EPS (diluted) | $-0.08 | $-0.24 | $-0.16 | $-0.23 | $-0.28 | $-0.22 | $-0.25 | $-0.33 |
| EPS (basic) | $-0.08 | $-0.24 | $-0.16 | $-0.23 | $-0.28 | $-0.22 | $-0.25 | $-0.33 |
| Operating margin | -$17 | -$63 | -$40 | -$60 | -$79 | -$56 | -$59 | -$76 |
| Net margin | -$19 | -$66 | -$41 | -$61 | -$81 | -$55 | -$58 | -$84 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $104.9M | $109.7M | $115.3M | $116.3M | $122.0M | $129.7M | $142.8M | $143.6M |
| Total liabilities | $52.0M | $55.8M | $51.4M | $52.0M | $52.0M | $52.1M | $55.3M | $48.6M |
| Stockholders' equity | $52.9M | $53.9M | $63.9M | $64.3M | $70.0M | $77.6M | $87.5M | $95.0M |
| Total current assets | $101.4M | $106.5M | $112.7M | $113.6M | $119.4M | $126.9M | $139.8M | $140.5M |
| Total current liabilities | $20.5M | $18.2M | $11.0M | $11.8M | $11.9M | $12.1M | $15.5M | $13.8M |
| Cash & equivalents | $79.8M | $85.0M | $92.0M | $92.4M | $101.5M | $108.8M | $120.4M | $118.6M |
| Accounts receivable | $11.4M | $10.6M | $9.7M | $9.7M | $9.6M | $9.4M | $10.8M | $12.9M |
| Inventory | $5.7M | $7.0M | $7.8M | $8.0M | $6.2M | $5.8M | $6.3M | $6.1M |
| Property, plant & equipment | $1.7M | $1.6M | $1.6M | $1.5M | $1.5M | $1.5M | $1.6M | $1.4M |
| Other non-current assets | $580.0K | $370.0K | $518.0K | $548.0K | $386.0K | $472.0K | $550.0K | $580.0K |
| Accounts payable | $1.9M | $1.5M | $1.3M | $1.7M | $2.1M | $2.8M | $1.7M | $1.3M |
| Accrued liabilities | $2.3M | $2.4M | $2.1M | $2.4M | $3.1M | $2.4M | $2.1M | $2.4M |
| Short-term debt | $10.1M | $3.8M | $0 | — | — | — | — | — |
| Long-term debt | $30.6M | $36.7M | $40.3M | $40.1M | $39.8M | $39.6M | $39.4M | $34.2M |
| Other non-current liabilities | $834.0K | $900.0K | $31.0K | $66.0K | $202.0K | $347.0K | $492.0K | $689.0K |
| Common stock & paid-in capital | $55.0K | $54.0K | $54.0K | $52.0K | $52.0K | $51.0K | $51.0K | $50.0K |
| Retained earnings | -$402.1M | -$397.7M | -$384.7M | -$380.6M | -$372.4M | -$360.5M | -$346.3M | -$334.5M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$5.7M | -$7.0M | -$1.8M | -$8.7M | -$7.5M | -$11.6M | -$3.5M | $362.0K |
| Investing cash flow | -$19.0K | -$60.0K | $156.0K | -$170.0K | -$210.0K | $0 | -$137.0K | -$51.0K |
| Financing cash flow | $474.0K | $88.0K | $1.3M | $25.0K | $485.0K | $16.0K | $5.4M | $76.0K |
| Free cash flow | -$5.7M | -$7.1M | -$1.7M | -$8.9M | -$7.8M | -$11.6M | -$3.6M | $311.0K |
| Capital expenditures | $19.0K | $60.0K | -$156.0K | $170.0K | $210.0K | $0 | $137.0K | $51.0K |
| Depreciation & amortization | $94.0K | $103.0K | $108.0K | $105.0K | $125.0K | $149.0K | $176.0K | $158.0K |
| Share-based compensation | $3.0M | $2.9M | $2.5M | $2.4M | $3.8M | $4.2M | $3.9M | $4.3M |
| Change in accounts receivable | $831.0K | $722.0K | $102.0K | $98.0K | $215.0K | -$1.3M | -$2.1M | -$7.2M |
| Change in inventory | -$1.3M | -$788.0K | -$214.0K | $1.8M | $406.0K | -$541.0K | $233.0K | -$704.0K |
| Change in accounts payable | $412.0K | $143.0K | -$398.0K | -$335.0K | -$688.0K | $1.1M | $377.0K | -$668.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $77.4M | $79.9M | $81.1M | $71.3M | $49.0M |
| Gross profit | $66.7M | $68.3M | $69.2M | $59.0M | $40.3M |
| Operating income | -$37.1M | -$50.5M | -$57.3M | -$84.0M | -$51.5M |
| Net income | -$38.4M | -$51.5M | -$55.5M | -$86.2M | -$63.0M |
| EPS (diluted) | $-0.74 | $-1.03 | $-1.14 | $-1.80 | $-2.36 |
| EPS (basic) | $-0.74 | $-1.03 | $-1.14 | $-1.80 | $-2.36 |
| Operating margin | -$48 | -$63 | -$71 | -$118 | -$105 |
| Net margin | -$50 | -$64 | -$69 | -$121 | -$129 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $115.3M | $142.8M | $166.7M | $213.1M | $280.2M |
| Total liabilities | $51.4M | $55.3M | $46.4M | $53.0M | $48.1M |
| Stockholders' equity | $63.9M | $87.5M | $120.2M | $160.1M | $232.1M |
| Total current assets | $112.7M | $139.8M | $162.9M | $209.7M | $277.0M |
| Total current liabilities | $11.0M | $15.5M | $12.3M | $17.8M | $13.5M |
| Cash & equivalents | $92.0M | $120.4M | $138.1M | $185.0M | $260.7M |
| Accounts receivable | $9.7M | $10.8M | $14.3M | $15.1M | $8.7M |
| Inventory | $7.8M | $6.3M | $7.8M | $6.1M | $3.5M |
| Property, plant & equipment | $1.6M | $1.6M | $1.6M | $1.6M | $1.5M |
| Other non-current assets | $518.0K | $550.0K | $682.0K | $211.0K | $202.0K |
| Accounts payable | $1.3M | $1.7M | $1.7M | $2.7M | $3.4M |
| Accrued liabilities | $2.1M | $2.1M | $1.6M | $5.3M | $2.7M |
| Long-term debt | $40.3M | $39.4M | $31.7M | $33.3M | $32.7M |
| Other non-current liabilities | $31.0K | $492.0K | $2.5M | $1.9M | $1.9M |
| Common stock & paid-in capital | $54.0K | $51.0K | $49.0K | $48.0K | $48.0K |
| Retained earnings | -$384.7M | -$346.3M | -$294.8M | -$239.2M | -$153.0M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$29.7M | -$22.4M | -$47.2M | -$76.0M | -$52.5M |
| Investing cash flow | -$224.0K | -$385.0K | -$791.0K | -$970.0K | -$813.0K |
| Financing cash flow | $1.8M | $5.0M | $1.1M | $1.2M | $252.5M |
| Free cash flow | -$29.9M | -$22.7M | -$48.0M | -$76.9M | -$53.4M |
| Capital expenditures | $224.0K | $385.0K | $791.0K | $970.0K | $813.0K |
| Depreciation & amortization | $487.0K | $712.0K | $614.0K | — | — |
| Share-based compensation | $13.1M | $17.1M | $14.6M | $13.0M | $5.1M |
| Change in accounts receivable | -$912.0K | -$3.5M | -$661.0K | $6.8M | $3.7M |
| Change in inventory | $1.4M | -$1.6M | $2.2M | $3.3M | $1.3M |
| Change in accounts payable | -$348.0K | $336.0K | -$883.0K | -$694.0K | $1.2M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding SGHT as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-04-01 to 2026-10-02
Recent transactions
- Insiders have net sold 154,284 shares over the last 182 days, across 1 purchase and 12 sales.
- Most recent: Taylor Brenton (EVP, Operations & R&D) — Open market sale of 2,988 shares on 2026-10-02.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)14,100 sh(1 txns)
Sales (open market)168,384 sh(12 txns)
Net Shares-154,284
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Taylor Brenton | EVP, Operations & R&D | Open market sale | 2026-10-02 | 2,988 |
| Bauerlein Alison | Chief Operating Officer | Open market sale | 2026-10-02 | 25,260 |
| Rodberg James | Chief Financial Officer | Open market sale | 2026-10-02 | 7,208 |
| Badawi David | Chief Technology Officer | Open market sale | 2026-10-01 | 7,797 |
| Badawi Paul | President and CEO | Open market sale | 2026-10-01 | 29,653 |
| Rashid Kashif | Chief Legal Officer | Grant / award | 2026-08-10 | 181,818 |
| HAYDEN JEREMY B. | Chief Legal Officer | Open market sale | 2026-07-06 | 12,733 |
| Encrantz Staffan | Reporting person | Open market purchase | 2026-06-10 | 14,100 |
| Fountain Tamara | Reporting person | Grant / award | 2026-06-04 | 28,261 |
| Burbach Gerhard F | Reporting person | Grant / award | 2026-06-04 | 28,261 |
| Zurbay Donald | Reporting person | Grant / award | 2026-06-04 | 28,261 |
| Mazzacco Catherine | Reporting person | Grant / award | 2026-06-04 | 28,261 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-02 | Taylor Brenton | EVP, Operations & R&D | Open market sale | 2,988 | $8.85 |
| 2026-10-02 | Bauerlein Alison | Chief Operating Officer | Open market sale | 25,260 | $8.85 |
| 2026-10-02 | Rodberg James | Chief Financial Officer | Open market sale | 7,208 | $8.85 |
| 2026-10-01 | Badawi David | Chief Technology Officer | Open market sale | 7,797 | $9.05 |
| 2026-10-01 | Badawi Paul | President and CEO | Open market sale | 29,653 | $9.05 |
| 2026-08-10 | Rashid Kashif | Chief Legal Officer | Grant / award | 181,818 | $0.00 |
| 2026-07-06 | HAYDEN JEREMY B. | Chief Legal Officer | Open market sale | 12,733 | $5.51 |
| 2026-07-06 | Badawi David | Chief Technology Officer | Open market sale | 7,418 | $5.51 |
| 2026-07-02 | Rodberg James | Chief Financial Officer | Open market sale | 6,902 | $5.36 |
| 2026-07-02 | Bauerlein Alison | Chief Operating Officer | Open market sale | 24,184 | $5.36 |
| 2026-07-01 | Taylor Brenton | EVP, Operations & R&D | Open market sale | 2,829 | $5.42 |
| 2026-07-01 | Badawi Paul | President and CEO | Open market sale | 28,684 | $5.42 |
| 2026-06-10 | Encrantz Staffan | Reporting person | Open market purchase | 14,100 | $4.88 |
| 2026-06-04 | Fountain Tamara | Reporting person | Grant / award | 28,261 | $0.00 |
| 2026-06-04 | Encrantz Staffan | Reporting person | Grant / award | 28,261 | $0.00 |
| 2026-06-04 | Burbach Gerhard F | Reporting person | Grant / award | 28,261 | $0.00 |
| 2026-06-04 | Zurbay Donald | Reporting person | Grant / award | 28,261 | $0.00 |
| 2026-06-04 | Mazzacco Catherine | Reporting person | Grant / award | 28,261 | $0.00 |
| 2026-05-18 | Bauerlein Alison | Chief Operating Officer | Open market sale | 12,728 | $5.12 |
| 2026-04-06 | Rodberg James | Chief Financial Officer | Open market sale | 7,231 | $3.55 |
| 2026-04-06 | HAYDEN JEREMY B. | Chief Legal Officer | Open market sale | 13,761 | $3.55 |
| 2026-04-02 | Bauerlein Alison | Chief Operating Officer | Open market sale | 25,874 | $3.48 |
| 2026-04-02 | Badawi David | Chief Technology Officer | Open market sale | 8,168 | $3.48 |
| 2026-04-01 | Taylor Brenton | EVP, Operations & R&D | Open market sale | 2,869 | $3.70 |
| 2026-04-01 | Badawi Paul | President and CEO | Open market sale | 29,244 | $3.70 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 08:24 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-05 | 4 | 2026-10-02 | View on SEC.gov → |
| 2026-10-05 | 4 | 2026-10-02 | View on SEC.gov → |
| 2026-10-05 | 4 | 2026-10-02 | View on SEC.gov → |
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-08-10 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-08-05 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-06 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-02 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-06 | View on SEC.gov → |
Recent news
Headlines about SGHT (Sight Sciences, Inc.). Links open the publisher — we don’t host full articles.
-
Sight Sciences Q3FY27 Results: Earnings call set for November 4
scanx.trade · 2026-10-22 -
Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
Yahoo · 2026-10-21 -
Precision Trading with SGHT Corporation (SGHT) Risk Zones
Stock Traders Daily · 2026-10-19 -
Form 144 Sight Sciences For: 18 October By Investing.com
Investing.com South Africa · 2026-10-18 -
H.C. Wainwright starts coverage of Sight Sciences stock with USD 14.00 target - ad-hoc-news.de
ad-hoc-news.de · 2026-10-16 -
Why Is Sight Sciences Stock Gaining Thursday?
Benzinga · 2026-10-15 -
This Eloxx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Benzinga · 2026-10-15 -
HC Wainwright & Co. Initiates Coverage On Sight Sciences with Buy Rating, Announces Price Target of $14
Benzinga · 2026-10-15
No headlines in this category right now — try “All”.